A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 9971 participants.

Also called NCT02099123

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 9,971 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02099123
Other papers using this trial's data
  • Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults The New England journal of medicine, 2026-10-01 DOI, PubMed 42670961

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02099123. Randomized; quadruple masking; primary purpose prevention. Start 2015-07 (registry gives no type); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE)
Acronym
STAREE
Condition
Independent Living
Condition
Disability Free Survival
Condition
Elderly
Condition
Healthy
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Placebo (for Atorvastatin)
Lead sponsor
Monash University (class: other)
Collaborator
National Health and Medical Research Council, Australia (class: other)
Collaborator
National Heart Foundation, Australia (class: other)

Record details

Record id
cardio:ct-nct02099123
Content hash
f3e0058196336d465d92f2507153fe36acf6fa8ae2a2b4f5aea0450db2120f7b